Trial Profile
Collaborative study for HyperglycemIc patients by Pitavastatin INtervention.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2013
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Sitagliptin
- Indications Diabetes mellitus; Hyperglycaemia
- Focus Therapeutic Use
- Acronyms CHIP-IN
- 18 Jan 2012 Planned number of patients changed from 120 to 100 as reported by University Hospital Medical Information Network - Japan.
- 18 Jan 2012 Planned end date 1 Jul 2012 added as reported by University Hospital Medical Information Network - Japan.
- 18 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.